Alden Kandic Email

Head Quality, VP . SmartCella Holding AB

Current Roles

Employees:
78
Revenue:
$12.1M
About
SmartCella is a global biotech company pioneering the future of targeted therapies through delivery solutions and advanced therapy development. Founded in 2014, the company is built on globally renowned science and research from Karolinska Institutet in Sweden.\n\nSmartCella combines novel delivery platforms, such as the Extroducer® (an endovascular delivery device that enables direct injection to hard-to-reach organs and tumors), with state-of-the-art development and manufacturing of stem cell-based therapies. The company operates in two business segments: Targeted Deliveries and Regenerative Medicines.\n\nThe international team consists of scientists, visionary innovators, and experienced business leaders, all dedicated to shaping the future of targeted therapies and delivering life-changing treatments to patients.
SmartCella Holding AB Address

Tullinge, null
se
SmartCella Holding AB Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.